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Mammographic density refers to the amount of breast tissue that appears light on a mammogram. In most epidemiologic studies, mammographic density is analyzed as percent mammographic density (PMD). Women with high PMD (≥75%) have a 4-to 6-fold increased risk of breast cancer compared with women of the same age and body mass index (BMI) (weight (kg)/height (m) 2 ) with primarily fatty breasts (PMD ≤10%) (1) . PMD is negatively associated with age and BMI, which in turn are positively associated with breast cancer risk in the older age groups typically studied. BMI is negatively associated with risk of breast cancer for young women (e.g., prior to menopause), but the association is positive at an older age (e.g., after menopause) (2-4). Therefore, estimating BMI as a risk factor as a step function, such as is typically done in studies of PMD as a risk factor for breast cancer, is not appropriate, and models should allow for the BMI risk association to depend on age as a continuous variable.
A risk model including PMD as a measure of mammographic density does not allow the estimation of separate associations for mammographic nondense breast area (NDA) and measures of overall adiposity, such as BMI. In this context, it might be more appropriate to use absolute mammographic dense breast area (DA) as a measure of mammographic density. Many authors have reported strong positive associations between DA and breast cancer risk (5, 6) , whereas few have investigated the association between NDA and breast cancer risk with contrasting findings (5, 7-9) that are difficult to interpret (10, 11) . To try to clarify the relationship between mammographic density and BMI and breast cancer risk, we conducted a case-control study nested within the Melbourne Collaborative Cohort Study (MCCS) and estimated the associations of close-to-baseline measurements of DA, NDA, PMD, and BMI with breast cancer risk, allowing these associations to depend on age at diagnosis.
MATERIALS AND METHODS

Melbourne Collaborative Cohort Study
The MCCS is a prospective cohort study of 41,514 people (including 24,469 women) aged 27-76 years at baseline (12) . Recruitment occurred between 1990 and 1994. At baseline attendance, participants completed questionnaires relative to demographic characteristics, lifestyle, and diet; standard procedures were used to measure height and weight (3, 13) , from which BMI was calculated.
Obtaining mammograms through BreastScreen Victoria
BreastScreen Victoria is part of Australia's national breast cancer screening program, established in 1992 to offer free mammographic screening to women over 40 years of age. The target group for the screening program is women aged 50-69 years, who are invited for screening every 2 years. At screening, mammograms are taken, and information is collected on a range of variables. Women attending BreastScreen Victoria give consent for their results to be used for research and evaluation. In 2009, we conducted a record linkage between the MCCS and BreastScreen Victoria. Of the 24,469 women in the MCCS, 20,444 (84%) had attended BreastScreen Victoria at least once and were eligible for this study.
Nested case-control study
Cases were women with a first diagnosis of ductal carcinoma in situ or invasive adenocarcinoma of the breast (International Classification of Diseases for Oncology codes C50.0-C50.9) that occurred during follow-up between the baseline interview and December 31, 2007. Cases were ascertained by record linkage to the population-complete Victorian Cancer Registry and to the Australian Cancer Database. There were 800 breast cancer cases diagnosed during follow-up, including 120 ductal carcinoma in situ cases and 680 invasive breast cancer cases.
We designed a nested case-control study by using incidence density sampling with age as the time scale. For each breast cancer case, we randomly selected 4 women as controls from among those who had not been diagnosed with breast cancer at the age of diagnosis of the case (reference age). The controls were also matched on year of birth, year of MCCS baseline attendance, and country of origin (classified as Australia/New Zealand/United Kingdom/others, Italy, or Greece). The Cancer Council Victoria's human research ethics committee approved the study.
Sixty-nine percent of the women initially selected in the case-control sample had at least 1 mammogram between age at baseline and reference age. From these mammograms, we selected for the study the mammogram closest to baseline; measurements were taken by using the craniocaudal image of the contralateral breast with respect to the laterality of the tumor in the matching case. After we excluded women belonging to incomplete matching sets (i.e., no case or no controls), 590 cases and 1,695 controls (2,162 women) remained for analysis. Mammograms were taken between 1991 and 2007.
Measurement of mammographic density
Mammograms were digitized by the Australian Mammographic Density Research Facility at the University of Melbourne with an Array 2905 high-density film digitizer (Array Corporation Europe, Roden, the Netherlands). The digitized images were masked, and total breast area and DA were measured by using a semiautomated computer-assisted thresholding technique called Cumulus (Imaging Research Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada). NDA was calculated by subtracting DA from the total breast area. PMD was calculated by dividing DA by the total breast area. Images were measured by 2 independent readers (J.S. and K.K.) blind to the disease status of participants. Mammograms were read in sets of approximately 100 images. A random sample of 10% of the images was repeated within each set to assess within-reader reliability. The sample of mammograms repeated in the first set was also repeated in every fifth set to assess within-reader reliability between sets.
Statistical analysis
To estimate within-reader and between-reader reliabilities, we applied linear mixed-effects models and calculated intraclass correlation coefficients. DA, NDA, and PMD were transformed to the powers of 0.2, 0.5, and 0.3, respectively, to achieve normalization. The within-reader reliabilities were 0.96 for DA, 1.00 for NDA, and 0.97 for PMD for both readers. The between-reader reliabilities were 0.87 for DA, 0.99 for NDA, and 0.90 for PMD. Given the high between-reader reliability, we used the averages from the 2 readers for each of the measurements of DA, NDA, and PMD for the analyses.
We worked under the assumption of 2 alternative models representing the relationship between DA, NDA, BMI, and breast cancer risk ( Figure 1 ). In the first causal diagram (Figure 1A) , DA, NDA, and BMI are all causes of breast cancer; the diagram also indicates that the relationship between DA and NDA and breast cancer risk goes through a function F of these 2 variables, which we assume to be either a linear combination of the 2 or the proportion of DA over total breast area (the PMD). The correlation structure between DA, NDA, and BMI is represented by the latent (unmeasured) variables X, Y, and Z. In the second causal diagram ( Figure 1B ), DA and the latent variable Y are both causes of breast cancer, whereas NDA and BMI are not. For example, if we think of Y as the generic variable "fat," Figure 1A illustrates the assumption that fat causes breast cancer via its effects on both nondense area (fat in the breast) and BMI (overall body fat). Conversely, Figure 1B makes the assumption that fat is a risk factor for breast cancer irrespective of its distribution in the body, whereas NDA and BMI are both proxies for fat. Directed acyclic graph theory was used to identify the variables to include in the risk model (14) . The goodness of fit of the 4 models was compared by using the Bayesian information criterion (BIC) and the area under the receiver operating characteristic curve (AUC). BIC and AUC values are from the model including all the variables as pseudocontinuous.
Relative risks of breast cancer and their 95% confidence intervals were estimated by fitting conditional logistic regression. Interactions between BMI and reference age were included to allow the associations of BMI and risk to depend on age at diagnosis. Also, the potential dependence of the associations of DA and NDA with age were evaluated by introducing into the model their interaction with reference age. All models were adjusted for age at mammography. The potential confounding effect of the following variables was also examined for all women and for those with mammograms taken within 5 years since MCCS baseline: BMI at age 18-21 years (missing for 1% of cases and 1% of controls); age at menarche; parity, lactation, and menopausal status at baseline (missing for 2% of cases and 2% of controls); oral contraceptive and hormone replacement therapy use (missing for 0.8% of cases and 0.7% of controls); alcohol consumption and total energy intake from diet (no missing data). Because of the large number of incomplete sets caused by missing values in the covariates, the adjusted analysis was conducted by applying the unconditional logistic regression model adjusting for the matching variables (553 cases and 1,594 controls were without missing values and, of these, 468 cases and 1,352 controls had mammography within 5 years since baseline). Additional potential confounding for family history of breast cancer was also examined (data for this variable were obtained from BreastScreen Victoria and were missing for 9% of cases and 11% of controls).
DA and NDA were categorized into quintiles on the basis of their distributions in the controls, and their dose-response associations were evaluated by using pseudocontinuous variables defined as within-quintile medians. Variables were standardized to the mean and standard deviation of the controls. Tests for linear trend were performed on the pseudocontinuous variables by using the Wald test, and tests for departure from linearity were performed by using the likelihood ratio test comparing the model with quintiles versus the model with pseudocontinuous variables.
Sensitivity analyses were conducted under the following scenarios: 1) exclusion of ever users of hormone replacement therapy; 2) exclusion of cases diagnosed within 2 years of mammography and their matching controls; and 3) exclusion of ductal carcinoma in situ cases and their matching controls. All analyses were conducted by using Stata, version 12.1, software (StataCorp LP, College Station, Texas).
RESULTS
The characteristics of the study sample are reported in Table 1 , P = 0.14). DA and NDA were negatively correlated (Spearman's rank correlation = −0.32). BMI was positively correlated with NDA (Spearman's rank correlation = 0.62) and negatively correlated with DA (Spearman's rank correlation = −0.28). Table 2 reports the risk estimates for DA, NDA, PMD, and BMI according to the causal diagrams in Figure 1 . Models 1 and 2 refer to Figure 1A with F = DA + γ × NDA and F = DA / (DA + NDA) = PMD, respectively; models 3 and 4 refer to Figure 1B with BMI or NDA as a proxy for Y. There was no difference in the goodness of fit between the 2 models in Figure 1A (for model 1, BIC = 1,508 and AUC = 0.68; for model 2, BIC = 1,506 and AUC = 0.68), whereas models 3 and 4 gave a slightly worse fit (for model 3, BIC = 1,517 and AUC = 0.67; for model 4, BIC = 1,533 and AUC = 0.65).
DA was positively associated with breast cancer risk. In model 1, women in the fifth quintile of DA had a risk of breast cancer that was 2.73 (95% confidence interval (CI): 1.95, 3.83) times higher than that for women in the first quintile, and the relative risk for 1 standard deviation of DA was 1.50 (95% CI: 1.32, 1.70). There were only small differences in the estimate of the association between DA and breast cancer risk across the models, suggesting that DA is a risk factor independent of both NDA and BMI.
NDA was negatively associated with breast cancer risk in model 1 (relative risk for 1 standard deviation of NDA = 0.75, 95% CI: 0.65, 0.86). In model 4, in which NDA was included as a proxy for Y, its association was no longer significant.
In model 2, after adjustment for age and BMI, PMD was associated with breast cancer risk; women with more than 50% density had an increased risk of breast cancer compared with women with less than 5% density (relative risk = 4.43, 95% CI: 2.64, 7.41). There was no evidence of heterogeneity by age for the association between DA, NDA, or PMD and breast cancer risk in any of the fitted models (results not shown). In all fitted models, the association with BMI increased with age at diagnosis (P < 0.05 for all tests for interaction). The ages at diagnosis when BMI was predicted to change from being protective to being a risk factor were 42 years in model 1, 46 years in model 2, and 51 years in model 3.
The estimates from the unconditional, fully adjusted model conducted by using data from women without missing values in the covariates were very similar to those from the conditional unadjusted model. For model 1, the odds ratios per 1 standard deviation were 1.49 (95% CI: 1.30, 1.69) for DA and 0.79 (95% CI: 0.68, 0.91) for NDA; in model 2, the odds ratio for women with more than 50% DA was 3.76 (95% CI: 2.22, 6.38); in model 3, the odds ratio per 1 standard deviation of DA was 1.52 (95% CI: 1.34, 1.73); in model 4, the odds ratios per 1 standard deviation were 1.46 (95% CI: 1.28, 1.66) for DA and 0.97 (95% CI: 0.86, 1.10) for NDA. Similar results were obtained after further adjustment for family history of breast cancer and when the analyses were conducted using women with mammograms taken within 5 years since baseline (results not shown). Figure 2 shows the predicted relative risks for a woman with given DA and NDA values compared with a woman with DA, NDA, and BMI values all equal to the medians in the general population (calculated as the medians for the control group); for values of NDA in the third quintile, which is close to the population median, all models provided similar estimates of the relative risks irrespective of DA, whereas for more extreme values of NDA, they gave substantially different predictions. For example, compared to those for a woman with DA and NDA values equal to the population medians, the relative risks for a woman with DA and NDA values in the bottom quintile (very small breasts) varied between 1.14 (95% CI: 0.96, 1.36) in model 1 and 0.81 (95% CI: 0.76, 0.86) in model 3; for a woman with an NDA value in the top quintile and a DA value in the bottom quintile ( predominantly fatty breasts), the relative risks varied between 0.53 (95% CI: 0.43, 0.66) in model 1 and 0.81 (95%: 0.76, 0.86) in model 3. Excluding ever users of hormone replacement therapy, excluding cases diagnosed within 2 years from mammogram, or restricting the analyses to invasive cases did not make major changes to the findings above (results not shown).
DISCUSSION
Our data show that, consistent with prior reports in the literature, absolute DA and PMD are both positive risk factors for breast cancer. By using an approach based on causal path diagrams, we have shown that absolute NDA is inversely associated with breast cancer risk under the assumption that fat in the body and fat in the breast cause breast cancer through independent mechanisms, whereas it is not associated with breast cancer risk under the assumption that they are both proxies of the same risk factor (i.e., adiposity).
Our results for DA and PMD are consistent with those previously reported (1, (15) (16) (17) (18) (19) (20) . Also, the finding that the estimates for DA are not influenced by the inclusion of NDA or BMI in the model is in agreement with a previous report (8) . There is no consensus in the literature about the Mammographic Density and Risk of Breast Cancer 479 association between NDA and breast cancer risk; both positive (5) and negative (7-9) associations have been reported. In a study by Stone et al. (8) , the negative association disappeared after adjustment for DA. Our data suggest that the estimate of the association between NDA and breast cancer depends on the underlying causal model determining the covariates to be included in the model. After taking into account the age-dependent association of BMI with breast cancer risk, we observed an increasing strength of association between BMI and increasing age at diagnosis that was consistent across the models and has been previously observed using the MCCS data (3).
Our data slightly favor a causal process in which NDA and BMI are both determinants of breast cancer risk, suggesting that in postmenopause, peripheral fat would be positively associated with breast cancer risk, the more so for later-onset breast cancer, whereas fat in the breast would play a protective effect. The distribution of fat in the body as a risk factor for breast cancer has some biological plausibility. Peripheral fat after menopause could increase the risk of breast cancer by maintaining high levels of estrogens through the aromatization of androgens (21) . Instead, fat in the breast tissue could contribute to a decreased risk of breast cancer through its contribution to vitamin D3-induced growth regulation of ductal epithelium (10, 22) . Also, having an adipose breast could be indicative of adiposity during childhood (23), which is negatively associated with breast cancer risk possibly because of an effect mediated by insulinlike growth factor 1 (24, 25) . Insulinlike growth factor 1 is a recognized breast cancer risk factor (26) , and its level in adulthood has been found to be lower in women with a history of obesity at menarche (27) . Moreover, obesity during childhood could result in a decreased cumulative exposure to endogenous estrogens because of increased anovulatory cycles with a consequent decreased risk of postmenopausal breast cancer (24) . It has also been speculated that the negative association between nondense breast tissue and breast cancer risk could be due to the positive correlation between NDA and breast involution, which is a protective factor for breast cancer independent of mammographic density (28) . It has been noted that studies reporting a negative association between NDA and breast cancer risk determined breast area from the craniocaudal view, whereas those reporting a direct association used the mediolateral oblique view (11) . The mediolateral oblique view could potentially measure a greater nondense breast area by including body subcutaneous adipose tissue that would reflect an increase in BMI rather than an increase in breast adipose tissue. We measured mammographic density using a craniocaudal view.
We found that, as a linear combination, the best predictor of breast cancer risk (after adjustment for BMI as an increasing function of age at diagnosis) is F = DA -0.7 × NDA, where DA and NDA were fitted as pseudocontinuous variables corresponding to 1 standard deviation increase, and BMI was adjusted for as a standardized variable. However, DA and NDA are negatively correlated (Spearman's rank correlation = −0.3), so in a statistical sense, the estimates of association could be reflecting the same underlying phenomenon. If the true causal area (i.e., the area containing the causally related tissues) is a subset of what is considered by the observer to be "dense" area, the positive association with DA will be underestimated. This could then lead to a spurious negative association with NDA.
The main strengths of our study are its size and prospective design, as well as detailed information on the main risk factors for breast cancer and highly repeatable measurements of mammographic density. A possible limitation of our study is not having measurements of mammographic density at baseline; in fact, all of the measurements refer to mammograms taken between MCCS baseline and age at diagnosis of matched cases. However, mammographic density tracks strongly with age with correlations of 0.8 or more between mammograms taken 10 years apart (29) , and we have adjusted all measurements for age at mammogram. Moreover, the results do not change when restricting the study sample to women with mammograms taken within 5 years from baseline. Another possible limitation is that the study sample has been extracted from the MCCS participants who attended breast screening services at least once and might not be fully representative of the general population.
Determining the most appropriate causal model underlying the relationship between mammographic density, BMI, and breast cancer risk is essential before including mammographic density in risk prediction models. Our data are better fitted by a model in which body and breast adiposity are independent risk factors for breast cancer than by a model in which they are proxies of the same risk factor. However, in terms of AUC and BIC, the differences between the fitted models are minimal and do not allow us to draw a definitive conclusion. We have shown that, for women with NDA equal to the median in the population, the models are similar in their predictions, whereas for women with very low or very high values of NDA, they provide quite different predictions. A validation study conducted on a sample of women with extreme values of NDA might help to determine which of these models provides a better fit to the data. ) equal to the population median by levels of dense and nondense mammographic areas compared with a woman with dense and nondense areas equal to the population median. Models 1, 2, 3, and 4 are those described in Table 2 . A) Nondense area = quintile 1; B) nondense area = quintile 3; and C) nondense area = quintile 5.
Our study adds to the evidence from the literature regarding the positive association between DA and breast cancer risk, showing that the estimate of the association does not depend on the choice of the causal model. The role played by NDA is more complex, and we have shown that its association with breast cancer risk is negative or null depending on the causal model underlying the relationships between DA, NDA, BMI, and breast cancer risk. Elucidating the biological mechanisms regulating the distribution of adipose tissue in the body and the breasts and breast cancer risk might help to determine the proper causal model and, consequently, to provide better estimates of an individual's risk of breast cancer.
